While the US Food and Drug Administration has been working to speed up the time it takes for drugs to garner approval, Commissioner Margaret Hamburg says that the sequester may slow those efforts, the Boston Herald reports. Speaking to the Massachusetts Biotechnology Council annual meeting attendees, Hamburg added that she would like Congress to allow FDA to access the user fees it collects to pay for its operating costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.